Similar articles

• Clinical validity of Banff grading of chronic rejection in renal transplantation.

  Oh CK, Jeong HJ, Kim YS, Kim MS, Choi KH, Lee HY, Han DS, Park K. Oh CK, et al. Transplant Proc. 1996 Jun;28(3):1441-2. Transplant Proc. 1996. PMID: 8658731 No abstract available.
• Influence of renal mass on chronic kidney allograft rejection in rats.

  Heemann UW, Azuma H, Tullius SG, Mackenzie HS, Schmid C, Brenner BM, Tilney NL. Heemann UW, et al. Transplant Proc. 1995 Feb;27(1):549. Transplant Proc. 1995. PMID: 7879094 No abstract available.
• Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction.

  Divella C, Rossini M, Loverre A, Schena A, Maiorano A, Gesualdo V, Zaza G, Grandaliano G, Schena FP. Divella C, et al. Nephrol Dial Transplant. 2010 Dec;25(12):4071-7. doi: 10.1093/ndt/gfq377. Epub 2010 Jun 30. Nephrol Dial Transplant. 2010. PMID: 20595199
• Post-transplantation histology as surrogate marker for long-term kidney allograft outcome.

  Yilmaz S, Nutley M, Taskinen E, Paavonen T, Häyry P. Yilmaz S, et al. Ann Transplant. 2000;5(2):37-43. Ann Transplant. 2000. PMID: 11217205 Review. No abstract available.
• Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.

  Yilmaz S, Taskinen E, Häyry P, Isoniemi H. Yilmaz S, et al. Transplant Proc. 1996 Feb;28(1):491-3. Transplant Proc. 1996. PMID: 8644324 Review. No abstract available.